Intraoperative radiotherapy for brain metastases: first-stage results of a single-arm, open-label, phase 2 trial

被引：0
|
作者：
Douglas Guedes de Castro
Paulo Issamu Sanematsu
Antônio Cassio Assis Pellizzon
Sérgio Hideki Suzuki
Ricardo Cesar Fogaroli
José Eduardo Souza Dias
Guilherme Rocha Melo Gondim
Daniel Alvarez Estrada
Maria Letícia Gobo Silva
Marcio Saquy Rassi
Michael Jenwei Chen
Richard Giacomelli
Henderson Ramos
Elson Santos Neto
Carolina Humeres Abrahão
Tharcisio Machado Coelho
Liao Shin Yu
Cassio de Queiroz Tannous
Vinicius Fernando Calsavara
Frank Anton Giordano
Jean Gonçalves de Oliveira
机构：
[1] A.C. Camargo Cancer Center,Department of Radiation Oncology
[2] A.C. Camargo Cancer Center,Department of Neurosurgery
[3] A.C. Camargo Cancer Center,Department of Imaging
[4] Cedars-Sinai Medical Center,Samuel Oschin Comprehensive Cancer Institute
[5] Heidelberg University,Department of Radiation Oncology, DKFZ
[6] Santa Casa de São Paulo School of Medical Sciences,Hector Cancer Institute, Medical Faculty Mannheim
来源：
Journal of Neuro-Oncology | 2023年 / 162卷
关键词：
Brain metastases; Neurosurgery; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：211 / 215
页数：4
相关论文
共 50 条
  • [21] Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
    Morschhauser, Franck
    Tilly, Herve
    Chaidos, Aristeidis
    McKay, Pamela
    Phillips, Tycel
    Assouline, Sarit
    Batievi, Connie Lee
    Campbell, Phillip
    Ribrag, Vincent
    Damaj, Gandhi Laurent
    Dickinson, Michael
    Jurczak, Wojciech
    Kazmierczak, Maciej
    Opat, Stephen
    Radford, John
    Schmitt, Anna
    Yang, Jay
    Whalen, Jennifer
    Agarwal, Shefali
    Adib, Deyaa
    Salles, Gilles
    LANCET ONCOLOGY, 2020, 21 (11): : 1433 - 1442
  • [22] Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
    Gelderblom, Hans
    Cropet, Claire
    Chevreau, Christine
    Boyle, Richard
    Tattersall, Martin
    Stacchiotti, Silvia
    Italiano, Antoine
    Piperno-Neumann, Sophie
    Le Cesne, Axel
    Ferraresi, Virginia
    Penel, Nicolas
    Duffaud, Florence
    Cassier, Philippe
    Toulmonde, Maud
    Casali, Paolo
    Taieb, Sophie
    Guillemaut, Severine
    Metzger, Severine
    Perol, David
    Blay, Jean-Yves
    LANCET ONCOLOGY, 2018, 19 (05): : 639 - 648
  • [23] Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
    Wang, Xuan
    Wu, Xiaowen
    Yang, Yue
    Xu, Weiran
    Tian, Hui
    Lian, Bin
    Chi, Zhihong
    Si, Lu
    Sheng, Xinan
    Kong, Yan
    Zhou, Li
    Mao, Lili
    Li, Siming
    Tang, Bixia
    Yan, Xieqiao
    Bai, Xue
    Guo, Jun
    Cui, ChuanLiang
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 57 - 65
  • [24] Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
    Necchi, A.
    Lo Vullo, S.
    Giannatempo, P.
    Raggi, D.
    Calareso, G.
    Togliardi, E.
    Crippa, F.
    Pennati, M.
    Zaffaroni, N.
    Perrone, F.
    Busico, A.
    Colecchia, M.
    Nicolai, N.
    Mariani, L.
    Salvioni, R.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1346 - 1351
  • [25] Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
    Margolin, Kim
    Ernstoff, Marc S.
    Hamid, Omid
    Lawrence, Donald
    McDermott, David
    Puzanov, Igor
    Wolchok, Jedd D.
    Clark, Joseph I.
    Sznol, Mario
    Logan, Theodore F.
    Richards, Jon
    Michener, Tracy
    Balogh, Agnes
    Heller, Kevin N.
    Hodi, F. Stephen
    LANCET ONCOLOGY, 2012, 13 (05): : 459 - 465
  • [26] Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial
    Tanimura, Keiko
    Uchino, Junji
    Kimura, Hideharu
    Hiranuma, Osamu
    Chihara, Yusuke
    Tanzawa, Shigeru
    Takumi, Chieko
    Kita, Toshiyuki
    Inoue, Koji
    Minato, Koichi
    Takemoto, Shinnosuke
    Nakao, Akira
    Yoshimura, Kenichi
    Takayama, Koichi
    ONCOLOGIST, 2023, 28 (06): : 551 - +
  • [27] Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
    Park, Joon Oh
    Feng, Yin-Hsun
    Su, Wu-Chou
    Oh, Do-Youn
    Keam, Bhumsuk
    Shen, Lin
    Kim, Sang-We
    Liu, Xiufeng
    Liao, Huimin
    Qing, Min
    Zhang, Chong
    Qian, Jiaqi
    Tang, Xiaodan
    Li, Peng
    Triantos, Spyros
    Sweiti, Hussein
    BMC CANCER, 2024, 24 (01)
  • [28] A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor
    Limon, Dror
    Amiel, Alexandra
    Haim, Shaked Even
    Gordon, Noa
    Tschernichovsky, Roi
    Stemmer, Salomon
    Gal, Omer
    Laviv, Yosef
    Kanner, Andrew
    Siegal, Tali
    Yust-Katz, Shlomit
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [29] Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: An open-label single-arm, phase II trial.
    Chen, Mingyuan
    Hua, Yijun
    You, Rui
    Wang, Zhi-Qiang
    Huang, Peiyu
    Lin, Mei
    Ouyang, Yan-Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
    Agulnik, Mark
    Schulte, Brian
    Robinson, Steven
    Hirbe, Angela C.
    Kozak, Kevin
    Chawla, Sant P.
    Attia, Steven
    Rademaker, Alfred
    Zhang, Hui
    Abbinanti, Susan
    Cehic, Rasima
    Monga, Varun
    Milhem, Mohammed
    Okuno, Scott
    Van Tine, Brian A.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208
12345